Price
Target price
?
?
2.310%
0.03
2.310%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for CMS
sharewise wants to provide you with the best news and tools for CMS, so we directly link to the best financial data sources.
Financials
News
Mobia Medical Q2 Earnings Call Highlights
Key Points
- Interested in Mobia Medical, Inc.? Here are five stocks we like better.
- Mobia Medical reported strong commercial growth: Second-quarter revenue doubled year over year to $13.5
Fractyl Health Q2 Earnings Call Highlights
Key Points
- Interested in Fractyl Health, Inc.? Here are five stocks we like better.
- Revita showed durable weight-loss maintenance: Patients retained more than 80% of prior GLP-1-related weight
CeriBell Q2 Earnings Call Highlights
Key Points
- Interested in CeriBell, Inc.? Here are five stocks we like better.
- Second-quarter revenue rose 33% year over year to $28.1 million, driven by higher utilization at existing
OPAL Fuels Q2 Earnings Call Highlights
Key Points
- Interested in OPAL Fuels Inc.? Here are five stocks we like better.
- OPAL Fuels reported strong second-quarter results: Adjusted EBITDA rose 40% year over year to $23.1 million and
PACS Group Q2 Earnings Call Highlights
Key Points
- Interested in PACS Group, Inc.? Here are five stocks we like better.
- PACS Group delivered strong Q2 growth: Revenue rose 9.1% year over year to $1.43 billion, net income increased 50%
Oscar Health Q2 Earnings Call Highlights
Key Points
- Interested in Oscar Health, Inc.? Here are five stocks we like better.
- Oscar Health reported record first-half profitability, including $1.1 billion in operating earnings and $1
TriSalus Life Sciences Q2 Earnings Call Highlights
Key Points
- Interested in TriSalus Life Sciences, Inc.? Here are five stocks we like better.
- Revenue rose modestly to $11.4 million in Q2, up 1.7% year over year, while TriSalus reiterated its
Nutex Health Q2 Earnings Call Highlights
Key Points
- Interested in Nutex Health Inc.? Here are five stocks we like better.
- Profitability improved sharply despite lower revenue: Second-quarter revenue fell 13.6% to $210.8 million, but
Sanuwave Health Q2 Earnings Call Highlights
Key Points
- Interested in Sanuwave Health Inc.? Here are five stocks we like better.
- Second-quarter revenue fell 3% year over year to $9.7 million, as a 34% decline in UltraMIST system sales
Privia Health Group Q2 Earnings Call Highlights
Key Points
- Interested in Privia Health Group, Inc.? Here are five stocks we like better.
- Strong Q2 performance: Privia Health’s implemented providers grew 10.1%, attributed lives increased
The Pennant Group Q2 Earnings Call Highlights
Key Points
- Interested in The Pennant Group, Inc.? Here are five stocks we like better.
- Strong Q2 performance: Revenue rose 35.8% year over year to $298 million, while adjusted EBITDA increased
Clover Health Investments Q2 Earnings Call Highlights
Key Points
- Interested in Clover Health Investments, Corp.? Here are five stocks we like better.
- Clover Health reported strong second-quarter results: Medicare Advantage membership rose 48%
Carlsmed Q2 Earnings Call Highlights
Key Points
- Interested in Carlsmed, Inc.? Here are five stocks we like better.
- Carlsmed’s Q2 revenue rose 57% year over year to $18.9 million, driven by higher adoption of its aprevo lumbar
DaVita Q2 Earnings Call Highlights
Key Points
- Interested in DaVita Inc.? Here are five stocks we like better.
- DaVita reaffirmed its 2026 outlook after reporting second-quarter adjusted operating income of $579 million, adjusted
Inspire Medical Systems Q2 Earnings Call Highlights
Key Points
- Interested in Inspire Medical Systems, Inc.? Here are five stocks we like better.
- Second-quarter revenue fell 7.6% to $200.6 million as coding and reimbursement disruptions reduced
SiBone Q2 Earnings Call Highlights
Key Points
- Interested in SiBone? Here are five stocks we like better.
- Strong second-quarter performance: SiBone’s revenue rose 15.2% year over year to $56 million, driven by nearly 15% U.S
MiMedx Group Q2 Earnings Call Highlights
Key Points
- Interested in MiMedx Group, Inc? Here are five stocks we like better.
- MiMedx agreed to acquire Sanara MedTech for $35 per share, adding more than $100 million in surgical revenue and
CMS Energy Q2 Earnings Call Highlights
Key Points
- Interested in CMS Energy Corporation? Here are five stocks we like better.
- CMS Energy reaffirmed its 2026 adjusted EPS guidance of $3.83–$3.90 and introduced 2027 guidance of
Molina Healthcare Q2 Earnings Call Highlights
Key Points
- Interested in Molina Healthcare, Inc? Here are five stocks we like better.
- Molina Healthcare beat second-quarter expectations with adjusted EPS of $1.51 on $10.2 billion of premium
Elevance Health Q2 Earnings Call Highlights
Key Points
- Interested in Elevance Health, Inc.? Here are five stocks we like better.
- Elevance Health raised its 2026 adjusted EPS outlook after Q2 results beat expectations, now guiding to at
Nyxoah Touts Genio U.S. Launch Traction, Reimbursement Stability at Investor Day
Key Points
- Interested in Nyxoah SA? Here are five stocks we like better.
- Nyxoah said its U.S. Genio launch is gaining traction, citing 262 trained surgeons, 123 ordering customers, and 427
Addus HomeCare Says License Moratorium Won’t Slow Personal Care Growth, M&A
Key Points
- Interested in Addus HomeCare Corporation? Here are five stocks we like better.
- Addus HomeCare said the new federal moratorium on certain home health licenses should have little
GRAIL Says Galleri Demand Is Rising as NHS Talks, FDA Review Move Ahead
GRAIL (NASDAQ:GRAL) said demand for its Galleri multi-cancer early detection test has continued to grow despite recent headlines related
DocGo Targets Profitability as It Pivots to Mobile Health, Medical Transport
DocGo (NASDAQ:DCGO) Chief Executive Officer Lee Bienstock outlined the company’s transition away from COVID-related, migrant and emergency-response
BioStem Technologies Q1 Earnings Call Highlights
BioStem Technologies (OTCMKTS:BSEM) said its first quarter of 2026 marked a major shift in its business model following a late-January acquisition that moved the company’s focus from physician